LOGIN

International Epidemiology Databases to Evaluate AIDS

Home >> Publications >> Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.

Publication

Author(s):

Balestre E, Eholiê© SP, Lokossue A, Sow PS, Charurat M, Minga A, Drabo J, Dabis F, Ekouevi DK, Thiê©baut R; International epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration.

Pub Title:

Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.

Pub Date:

May 15 2012

Pub Region(s):

West Africa

Journal Issue:

8

Page Number:
951-7

Journal:

Title: 
AIDS
Link: 
http://journals.lww.com/aidsonline/pages/articleviewer.aspx?year=2012&issue=05150&article=00006&type=abstract

PubMed: 22382142
Pub PDF: PDF icon 22382142.pdf

Abstract
OBJECTIVE
: To assess the effect of aging on the immunological response to antiretroviral therapy (ART) in the West African context.

METHODS: The change in CD4 T-cell count was analysed according to age at the time of ART initiation among HIV-infected patients enrolled in the International epidemiological Database to Evaluate AIDS (IeDEA) Collaboration in the West African region. CD4 gain over 12 months of ART was estimated using linear mixed models. Models were adjusted for baseline CD4 cell count, sex, baseline clinical stage, calendar period and ART regimen.

RESULTS: The total number of patients included was 24,107, contributing for 50,893 measures of CD4 cell count in the first year of ART. The baseline median CD4 cell count was 144 cells/μl [interquartile range (IQR) 61-235]; median CD4 cell count reached 310 cells/μl (IQR 204-443) after 1 year of ART. The median age at treatment initiation was 36.3 years (10th-90th percentiles = 26.5-50.1). In adjusted analysis, the mean CD4 gain was significantly higher in younger patients (P < 0.0001). At 12 months, patients below 30 years recovered an additional 22 cells/μl on average [95% confidence interval (CI) 2-43] compared to patients at least 50 years.

CONCLUSION: Among HIV-infected adults in West Africa, the immunological response after 12 months of ART was significantly poorer in elderly patients. As the population of treated patients is likely to get older, the impact of this age effect on immunological response to ART may increase over time.

PMID: 22382142 [PubMed - indexed for MEDLINE]

PMCID: PMC3704338

 

The following websites provide guidelines and policies when citing from PubMed®: http://www.ncbi.nlm.nih.gov/books/NBK7243/
http://www.nlm.nih.gov/bsd/policy/cit_format.html

Citation:

Balestre E, Eholié SP, Lokossue A, Sow PS, Charurat M, Minga A, Drabo J, Dabis F, Ekouevi DK, Thiébaut R; International epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration. Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa. AIDS. 2012 May 15;26(8):951-7. doi: 10.1097/QAD.0b013e3283528ad4. PubMed PMID: 22382142; PubMed Central PMCID: PMC3704338.